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doi:10.1016/j.ejvs.2009.12.028Abstract The aim of the study was to describe the presentation management and short term
results of therapy (< 1 month) in patients admitted with HIV vasculopathy.
Records were culled from a prospectively maintained data base on the Vascular Unit at
Inkosi Albert Luthuli Hospital, Durban, South Africa between January 2005 and June 2009.
226 patients were studied; 111 had aneurysms and 115 occlusive disease. 98% were African
and ages ranged from 4e53 years (average 36); 90% were male. The CD4 count ranged from
1e930 cells/mm3 while serum albumin averaged 30 mMol/L.
202 aneurysm presented in 111 participants; commonest sites were superficial femoral
artery (40%) and carotid (25%). 82 patients had standard operative repair and 8 had stent
grafts; 29 were not treated due to advanced disease.
Within 30 days of operation the mortality was 9% with 5% developing graft sepsis and 11%
pulmonary complications.
Of 115 with occlusive disease, there were 2 distinct groups. 51 had no previous claudication
and had acute thrombosis; no thrombophilia could be demonstrated. 64 had premature athero-
sclerotic disease. The majority presented with critical ischaemia.
In the acute thrombosis group 15 (29%) had primary amputation, limb salvage was achieved
in 13 (36%) and 4 died (11%). In the chronic occlusive group 30 (47%) had primary amputation,
of 25 submitted to surgery limb salvage was achieved in 17 (68%).
Low CD4 count and albumen levels did not correlate with mortality or complications.
Conclusion: Surgical therapy for aneurysm is worthwhile in the short term.
Following occlusive disease there is a 25% overall salvage rate in the short term (< 1/12) but
the long term outlook is uncertain.
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Table 1 Distribution of HIV aneurysms n Z 202
(111 patients).
n %a
Carotid 50 25
Abdominal aorta & branches 41 20
Thoracic abdominal aorta 15 7
Lower limb 80 40
Upper limb 16 8
a Percentages to nearest whole number.
Table 2 HIV aneurysms.
Clinical presentation n Z 111 Total %a
Asymptomatic 50 45
Symptomatic:
Rupture 8
Compression 53
61 55
Advanced systemic disease 40 36
Deep-vein thrombosis 10 9
Tuberculosis 4 4
Kaposi sarcoma 1 1
a Percentages to nearest whole number.
S26 J.V. Robbs, N. ParukThe largest burden of human immunodeficiency virus
acquired immunodeficiency syndrome (HIV/AIDS) is found
in sub-Saharan Africa, which accounts for approximately
60% of people living with HIV worldwide.1
The HIV virus is a lentovirus, which invades lymphoid
tissue and can also be found in all bodily fluids. Particularly
clinically relevant are the genital secretions, breast milk
and blood. The HIV-1 viruses are found universally and
there are 11 subtypes. HIV-2 was found in West Africa and
has four subtypes. This is the Simian immunodeficiency
virus and the infection runs a much milder clinical course.
The natural history of the disease comprises an initial
acute illness, which lasts for a week or two followed by
a long quiescent phase, which may last for years during
which the immune system is progressively destroyed. The
terminal events are characterised by opportunistic infec-
tions and other acquired immunodeficiency syndrome
(AIDS)-defining conditions.
Monitoring during the quiescent phase entails measuring
the serum CD4 count and viral load. Antiretroviral therapy
is effective during this phase of the disease and inhibits
viral replication. Vasculopathies occur during the later
stages of the disease process and are a marker for advanced
disease.
HIV-related aneurysms were first reported in
Zimbabwe.2,3
Nair et al.4 first described the pathology in detail, which
was regarded as unique to HIV/AIDS vasculopathy. They
noted that the inflammation was centred on the vasa vasora
in the adventitia and was characterised by a vasculitis inFigure 1 Angiograms showing typical HIV aneurysms of thwhich the vessels were surrounded by a cuff of neutrophils,
monocytes and plasma cells, which ultimately lead to
occlusion of the vasa vasora with resultant transmural
fibrosis or necrosis and the formation of true or false
aneurysms. The exact pathogenesis is uncertain and there
is debate as to whether this is due to direct action of the
virus or an immune-complex mechanism. HIV protein is
noted in the lymphocytes of the vasa vasora but this can be
found in lymphocytes throughout the body. The obvious
question is whether opportunistic bacterial infection is
responsible. Studies on 92 aneurysms, which included
cultures and polymerase chain reaction (PCR) investigation,
revealed positive cultures in only three, which comprised
mixed organisms grown from an aneurysm clot.5
Occlusive disease is less well studied. HIV-related
thrombosis, which is segmental, shows a histological
picture identical to that seen in aneurysms, with inflam-
matory changes confined to the vasa vasora with bland
organising luminal thrombosis. This strongly suggests that
aneurysm and thrombosis are different expressions of the
same pathological process.6e8
There is also evidence to suggest that HIV infection
promotes the development of accelerated atherosclerosis
due to endothelial damage.9e11
This article presents a review of a 4-year experience
with HIV-related vasculopathies treated at the vascular
service at the Inkosi Albert Luthuli Central Hospital in
Durban, South Africa.e aorta and carotid artery, found in the same patient.
Table 3 Treatment of HIV aneurysms n Z 119
(111 patients).
n %a
Non operative 29 24
Operative:
Aorta 32
Carotid 28
Lower limb 20
82 69
Stent:
Subclavian 4
Carotid 3
Aorta 1
8 7
a Percentages to nearest whole number.
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The records of inpatients treated for HIV-related vascul-
opathy were extracted from a prospectively maintained
database at the Vascular Unit at Inkosi Albert Luthuli
Central Hospital in Durban from January 2005 to June 2009.
Case notes of 226 patients were found: 111 with aneu-
rysms and 115 with occlusive disease.
Patient ages ranged from 4 to 53 years and averaged 36
years: 90% were male and 98% were Africans.
The CD4 counts in this group ranged from 1 to
930 cells mm3 (normal 800e1200 cells mm3). (This was
indicative of advanced HIV disease.)
Serum albumin, which is an index of nutrition, ranged
from 12 mmol L1 to 45 mmol L1 and averaged
30.5 mmol L1 (normal 35e50 mmol L1).
Aneurysms
Table 1 shows the anatomical distribution of aneurysms and
it will be seen that they tend to be multiple. There were
a total of 202 aneurysms in 111 patients. The most common
site is the superficial femoral artery (40%) followed by the
carotid artery (25%).
In Table 2, the clinical presentation of aneurysms is
summarised. Almost half (45%) were asymptomatic, pre-
senting with a pulsatile mass or were incidentally discov-
ered on ultrasound or plain radiography, while 55%
presented with rupture or compressive symptoms. A total
of 36% had manifestations of advanced HIV disease with
weight loss, adenopathy or opportunistic infections such asTable 4 HIV aneurysms.
Post procedure results
within 1 month n Z 90
n Death Sepsis P
Operative
Aortic 32 3(9)a 0
Carotid 28 3(11) 2(7)
Lower limb 22 1(4) 2(9)
Stent 8 1(12) 1(12) e
Total 90 8(9) 5(5) 1
a Percentages to nearest whole number.candidiasis or pneumonia. Radiographs showing typical
aneurysms are displayed in Fig. 1.
Treatment of the aneurysm is shown in Table 3 in which
119 aneurysms were treated in 111 patients. A total of 29
patients (24%) were assessed to be too ill for treatment due
to advanced disease or they refused treatment.
Operative repair was offered to 82 patients (69%); 32
aortic replacements, 28 carotid repairs and 20 lower limb
repairs were performed. These used standard replacement
techniques using prosthetic grafts in 57 (70%) or vein grafts
in 25 (30%).
More recently, stent grafts have been used in eight
patients; subclavian in four, carotids in three and aorta in
one.
The results of aneurysm treatment within 1 month of the
procedures can be seen in Table 4. Following 32 aortic
replacements, three patients died (9%) e all of multiple-
organ failure while three of 28 patients with carotid
replacement died (11%). One of 22 patients with lower limb
reconstructions died (4%) and one of the eight stented
patients died following a subclavian procedure in which the
stent became infected resulting in exsanguinating
haemorrhage 2 weeks later.
The overall mortality in the total of 80 patients
submitted to surgery was 9%, with 5% developing graft
sepsis and 11% significant pulmonary infection.
All postoperative results are reported at 1 month after
operation. The hospital is a tertiary referral centre and
patients are then referred back to base hospitals for further
long-term therapy. At this stage, reliable longer term
results are not available.
Occlusive Disease
Table 5 summarises the clinical presentation of the 115
patients with occlusive disease.
There were two distinct groupseone in which there was
no antecedent claudication and who presented with acute
thrombosis. Angiographically, proximal vessels appeared
normal but there was segmental occlusion with poor distal
runoff. A typical angiogram is shown in Fig. 2. It is of
interest to note that duplex Doppler showed what appeared
to be a pathognomonic beading in the vessel wall (Fig. 3).
A total of 51 patients presented with acute thrombosis
(44%). The coagulation profile, which included international
normalised ratio (INR) platelet count, protein C and S
levels, antilupus antibody, serum fibrinogen andneumonia MOF Cranial nerve injury Stroke
5(16) 7(22) e e
4(14) e 1(4) 2(7)
1(4) e e e
e e e
0(11) 7(8) e e
Table 5 HIV occlusive disease.
Clinical presentation n Z 115 n % a
Acute thrombosis 51 44
Chronic:
Critical ischaemia 59 64 56
Claudication 5
Associated disease
Deep-vein thrombosis 3 3
Tuberculosis 9 8
Kaposi Sarcoma 1 1
a Percentages to nearest whole number.
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comprehensive investigation was carried out in only 15
patients, as economic factors precluded this as a routine.
The second group with occlusive disease appeared to
have premature atherosclerotic disease and it comprised 64
patients (56%). The majority presented with critical
ischaemia with rest pain or gangrene.
Management of the acute thrombosis group is shown in
Table 6. Fifteen (29%) patients had primary amputation asFigure 2 Angiogram series showing typical acute thrombosis. Nothe limbs were deemed unsalvageable. In 33 of 36 (71%)
patients, salvage was attempted comprising thrombectomy
with or without thrombolysis; bypass was attempted in the
remaining three patients. Of the 64 patients, who had
chronic occlusive disease, primary amputation was neces-
sary in 30 (47%) while no treatment was offered to nine
(14%) who were deemed to be preterminal. Twenty-one
patients were offered bypass surgery, and four an endo-
vascular procedure (Table 7).
Results within 1 month of attempted limb salvage in 36
patients with acute thrombosis are shown in Table 8. Limb
salvage was achieved in 13 (36%), while 23 (64%) resulted in
an amputation. Four patients in this group died (11%).
Of 25 patients in the chronic occlusive group, salvage
was achieved in 17 (68%) while eight (32%) resulted in
amputation. Three patients (12%) died.
Of the entire group of 115 patients presenting with
occlusive disease, the limb salvage rate was 26% and the
mortality rate 6% (Table 9).
In the entire group including aneurysms as well as
occlusive disease, an attempt was made to correlate the
incidence of postoperative complications with the level of
serum albumin and the CD4 count in 110 patients in whom
the information was complete. Serum albumin ofte normal appearing proximal vessels with poor distal runoff.
Figure 3 Duplex scan showing typical hyper echoic areas
within the vessel wall giving a beaded appearance.
Table 7 Management of HIV related chronic occlusive
disease.
Chronic occlusive
disease n Z 64
n % a
Primary amputation 30 47
Bypass 21 33
Endovascular 4 6
No treatment 9 14
a Percentages to nearest whole number.
Table 8 Results within 1 month of attempted limb salvage
Management of HIV Vasculopathy S2935 mmol L1 and a CD4 count of 200 cells mm3 were used
as the critical values. There was no difference in the
patient mortality or complications.
Discussion
There is an increasing incidence of HIV-related vasculop-
athy in our practice.
While females are most commonly affected by HIV
infection in our environment, there is a distinct male
predominance in HIV vasculopathy. This corroborates other
reports, but the reason for this is obscure.5,6,12,13
The HIV vasculopathies are a manifestation of advanced
disease as evidenced by the low average CD4 count of only
255 cells mm3 in this series, which is a finding similar to
those published by other authors.5,6,12,13
A total of 26% of patients with aneurysms and 9% of our
occlusive disease patients were not offered treatment due
to the severity of the systemic illness.
The multiplicity and sites of the aneurysms is also diffi-
cult to explain. As a general principle, if an aneurysm isTable 6 Management of HIV related thrombosis.
Thrombosis n Z 51 n % a
Attempted limb salvage 36 71
Thrombectomy/thrombolysis 33
Bypass, 3
Primary amputation 15 29
a Percentages to nearest whole number.found, then other sites should be screened for multiple
lesions.
Standard treatment has been offered for aneurysms,
including prosthetic grafts, and relatively recently, endo-
vascular therapy has been performed. Due to the fact that
the hospital is a tertiary level centre and patients are dis-
charged to peripheral hospitals for further long-term
therapy, the only reliable follow-up that we have to report
is for 1 month after the surgery. There is a smaller cohort
that has been followed up for 1 year and longer but the
information is not suitable for analysis and publication at
this stage. In the short term, perioperative mortality is
surprisingly low for all procedures. The most common
postoperative complication is pneumonia which, in those
that died in the perioperative period, progressively dete-
riorated and resulted in multiple-organ dysfunction. The
death that occurred following endovascular therapy fol-
lowed a stent that was inserted into a subclavian aneurysm,
which became grossly septic within the next 2e3 weeks
with resultant massive secondary haemorrhage.
In the short term, sepsis of both graft and wound is
relatively low. We have, however, seen some patients
returning within 6 months with a graft infection.
In relation to the occlusive disease, there appear to be
two distinct patterns. One is that of acute thrombosis
originally described by Mulaudzi et al.8 in which patients
have had minimal symptoms before presenting with acute
ischaemia and rest pain. The other group presents with
chronic ischaemia due to atherosclerosis.
In the acute thrombosis group, the angiographic picture
is one in which the proximal vessels are normal, accompa-
nied by aggressive peripheral thrombotic occlusion and very
poor distal runoff. Duplex Doppler shows a characteristic
picture of a ‘string of beads’ in the wall of the vessel; the
exact reason for this is uncertain, but it appears to be
pathognomonic. This has been described from our centre in
an earlier publication.14for HIV thrombosis.
n Z 36 n % a
Limb salvage 13 36
Amputation 23 64
Death 4 11
Pneumonia 5 14
Renal failure 1 3
Bowel necrosis 1 3
a Percentages to nearest whole number.
Table 9 Results within one month of attempted salvage in
patients with H.I.V chronic occlusive disease.
n Z 25 n % a
Salvage 17 68
Amputation 8 32
Death 3 12
Graft sepsis 2 8
a Percentages to nearest whole number.
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unfortunately done only in 15 patients due to economic
constraints, showed no significant abnormalities. This
corroborates an earlier report.8 Hence, we believe that the
major problem with the acute thrombotic occlusion is that
of the arteritic process resulting in thrombosis.
Venous thrombosis has been noted as a complication of
advanced disease and the impression is that there is a pro-
thrombotic process under these circumstances. Deep-vein
thrombosis was noted in only 5% of this particular group of
patients.
In studies on HIV-related venous thrombosis, several
authors have demonstrated protein S deficiency and this is
the only convincing evidence of an element of a pro-
thrombotic state.15e17 Others have noted anticardiolipin
antibodies,18 and protein C deficiency19 but there is no
clear evidence for any particular thrombophilia, and this is
probably a multifactorial phenomenon.
In the acute arterial thrombosis group in the present
series, 30% were beyond salvage and had a primary ampu-
tation. Thrombectomy and thrombolysis resulted in a 36%
salvage rate, with an 11% mortality related mainly to
pulmonary complications.
In the group with chronic occlusive disease, 90% of the
patients presented with critical ischaemia with focal
gangrene and rest pain. This was thought to be due to
atherosclerotic lesions occurring in a much younger group
of patients. It seems that peripheral arterial disease is more
prevalent with HIV infection and a six-fold increase has
been shown at an earlier stage compared with HIV-negative
patients.9e11 Due to the advanced disease, in almost half of
the patients, there was no possibility of reconstruction due
to poor runoff or the limb was beyond salvage. Standard
bypass procedures were performed in most patients and
only recently have endovascular procedures been attemp-
ted in our practice. In this group, the results are marginally
better than in the patients with acute thrombosis in that
there was a 68% salvage rate at 1 month with 12% mortality.
In the series of van Marle et al.,6 the results were very
similar at 1 month, and on follow-up of a limited number of
patients in the longer term, it was found that the ampu-
tation rate rose to approximately 29%.
In terms of prognostication as to which patients will
survive operation, some authors have noted that the CD4
count is important whilst others feel that the albumin, as
a reflection of nutrition, is important; but this is not borne
out in our own experience.20e24 In general, the incidence of
sepsis is surprisingly low in the short term, but it would
appear that this increases in the longer term, particularly in
relation to graft infections.A major issue is what the impact of antiretroviral
therapy might be on therapy for vasculopathies. Vasculop-
athy is a late manifestation of disease and could possibly be
construed as AIDS defining. It would appear that anti-
retroviral therapy may influence the postoperative results
and there is a desperate need for more accurate follow-up
and documentation in the longer term.
In conclusion, surgical therapy for aneurysms is worth-
while, in the short term.
Among the occlusive disease patients, there is an overall
approximate salvage rate of 25% and how this would be
carried into the longer term remains to be seen. It may
be argued that primary amputation for all patients may be
a better option. The influence of antiretroviral therapy
requires definition.
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